When you take a one-off prototype to a massive engineering firm, your invoice isn't just for materials and labor. You’re paying for their 401k matching, their sleek downtown offices, and the three layers of management that have to "approve" your design before it even touches a CNC machine.

When it comes to compliance, the FDA doesn't play games. Being “just the designer” is not a get-out-of-jail-free card for the new QMSR compliance guidelines. If the vendors creating your designs lack a QMS that satisfies ISO 13485 Design Controls, the owner of the product—that’s you—is the one left holding the bag of liability.

𝐅𝐢𝐫𝐬𝐭 𝐨𝐟𝐟, 𝐰𝐡𝐚𝐭 𝐢𝐬 𝐈𝐒𝐎 9001? At its core, ISO 9001 is a framework. It doesn't tell you 𝒉𝒐𝒘 to make your product. Instead, it tells you how to manage the 𝒑𝒓𝒐𝒄𝒆𝒔𝒔𝒆𝒔 that make the product.

It’s a classic story. You invest in a high-end AMR/AGV fleet or a custom conveyor system, only to realize a $10 component wasn't designed for your specific "real world" environment.

𝐘𝐨𝐮𝐫 $50𝐤 𝐀𝐆𝐕 𝐢𝐬 𝐛𝐞𝐢𝐧𝐠 𝐤𝐢𝐥𝐥𝐞𝐝 𝐛𝐲 𝐚 $5 𝐜𝐫𝐚𝐜𝐤 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐜𝐫𝐞𝐭𝐞.

The math for industrial automation in 2026 is looking pretty brutal. With labor scarcity and a rise in material costs, manufacturers are facing an uphill battle to protect their bottom line. 

The silent ROI killer we’re witnessing is 𝐯𝐢𝐛𝐫𝐚𝐭𝐢𝐨𝐧.

𝐒𝐭𝐨𝐩 letting your equipment shake itself to death! Mobile robots weren't meant to shake their booties.

They aren't auditioning for a competitive dance-off, yet vibration is out here causing mechanical failures and sensor-induced seizures.

The FDA’s 𝐐𝐌𝐒𝐑 (Quality Management System Regulation) isn't coming—it’s here as of February 2, 2026. This doesn’t come as a shock. In fact, the transition was officially announced with a two-year grace period enacted back in February 2024. So, my friends, the clock has officially run out.

We all see the forecasts—the global MedTech market is on track to hit $1.2 𝐭𝐫𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2035—but the reality is that "innovation" is getting harder.

Most early-stage medical devices fail because they can’t bridge the gap between a cool concept and a manufacturable reality.

When we talk about feasibility studies at 𝐒𝐭𝐞𝐫𝐥𝐢𝐧𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, 𝐓𝐄𝐋𝐎𝐒 isn’t just an acronym we throw around. It’s a lens through which we evaluate whether an idea is truly ready for reality.

There’s a quiet kind of satisfaction in helping someone bring an idea into the world.

Welcome back to Sterling Product Development’s Inside Product Development Blog Series. This post is going to tackle the “𝐎” in TELOS—𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐅𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲.

Welcome back to Sterling Product Development’s Inside Product Development Blog Series. This post is going to tackle the “L” in TELOS—the dreaded 𝐋𝐞𝐠𝐚𝐥 𝐅𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲.

Last time, we explored the “T” in TELOS: Technical Feasibility. Today we’re moving to the next piece: Economic Feasibility.

Previously we talked about the TELOS framework for feasibility testing. Today we are focusing on the first letter of that acronym: 𝐓 = 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐟𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲.

In a previous 𝐈𝐧𝐬𝐢𝐝𝐞 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 post we covered why feasibility testing is crucial and how there are several types of feasibility that should be checked before investing time and money in a new product. These tests fall under a framework known as 𝐓𝐄𝐋𝐎𝐒.

A while back, we shared a post that touched on 𝐟𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 and what it involves. That was the overview. Today, we are taking a deeper look at why feasibility testing matters so much in product development.

We want to bring your attention to a matter that affects our company’s integrity and your awareness.

Every product’s journey moves through stages, and one of the most critical is turning a patented concept into detailed engineering drawings.

Thank you.

We’re proud to share that 𝐒𝐭𝐞𝐫𝐥𝐢𝐧𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐋𝐋𝐂 is collaborating with 𝐕𝐢𝐜𝐫𝐨 𝐌𝐞𝐝 𝐋𝐋𝐂 on a fully patented external catheter, with clinical testing anticipated in 2025.